Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial Cancer | Synapse

October 17, 2024Open Access

Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial Cancer

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

This study is one of the largest cohorts of ctDNA currently reported in endometrial cancer. The presence of TP53 mutation and other comutations detected by ctDNA have a negative effect on outcomes. This report suggests that ctDNA analysis is feasible and could become a useful biomarker for endometrial cancer.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Pina et al. (Thu,) studied this question.

synapsesocial.com/papers/699ea8a4e3cefbce9425b200 https://doi.org/https://doi.org/10.1158/1078-0432.ccr-24-2105